The released minutes of the European Central Bank's April meeting show a dovish unity as the US tariff announcements added to disinflationary pressures in the Eurozone.
Q1 revenue rose 3.3% year over year to $18.75 million, while adjusted net income remained positive at $0.4 million, and operating cash flow was $0.2 million.
Gold trades near key resistance, supported by Fed rate cut expectations, U.S. debt concerns, and global tensions. A breakout could signal renewed bullish momentum.
Rocket Lab's upcoming mission for BlackSky's Gen-3 satellite has a scheduled launch window on May 28, 2025. This will be Rocket Lab's 7th Electron mission and marks their 65th launch to date. Investors can gain exposure through ARKX and RKLX. RKLB shares down 1.47% premarket.
BlackBerry's asset-tracking technology, Radar, will be deployed in 100,000 domestic chassis by Direct ChassisLink Inc., marking a major step in their partnership. This will enhance operational efficiency and asset visibility in the intermodal freight network.
Hims & Hers Health, Inc (NYSE:HIMS) is facing heavy selling pressure Thursday morning as the U.S. Food and Drug Administration's (FDA) ban of compounded drugs with semaglutide takes effect.
Truth+ is only one part of the Trump Media ecosystem, which also includes its flagship social media platform, Truth Social, and Truth.Fi, a financials and fintech brand.
